Myriad Genetics, Inc. Forecasted to Earn Q1 2025 Earnings of ($0.04) Per Share (NASDAQ:MYGN)
Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) – Equities research analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for shares of Myriad Genetics in a report released on Thursday, October 10th. Leerink Partnrs analyst P. Souda now expects that the company will post earnings of ($0.04) per share for the […]
16 Oct 06:16 · The Markets Daily